PMA-differentiated THP-1 cells were pre-treated with Caspase-3 inhibitor (C3I) or a chemical analog with no inhibitor activity (C3I-A) at 20 μM for 3 h before infection, during infection, and after infection. This evidence concerns the gene CASP3 and infection.